Acne vulgaris is a chronic inflammatory disorder of the pilosebaceous unit affecting more than 85% of adolescents and often persisting into later adulthood. Conventional therapy with antibiotics and retinoids yield mixed results and can be complicated by antibiotic resistance and adverse treatment profiles.
Acne can be a side effect of testosterone replacement therapy or of anabolic steroid use.
Acne vulgaris is sensitive to hormonal influences. Historical and physical clues that may suggest hormone-sensitive acne include onset between ages 20 and 30; worsening the week before a woman’s menstrual cycle; acne lesions predominantly over the jawline and chin; and inflammatory/nodular acne lesions.
Manufactured in Canada, Health Canada licensed under MDSAP, ISO 13485-2016 quality management. IEC 60601-1-2 EMC/EMI approved, CSA/NRTL certified. Protected by multiple US and Canadian patents.
Read manual before using. Not tested on pregnant women. Epilepsy sufferers should not use this device.
Email: info@acnelite.net
Telephone: 1 (866) 622-7803, Monday to Friday, 9 am to 5 pm, EST.